Ansa Biotechnologies’ CEO Daniel Lin-Arlow’s passion is helping scientists do their job faster and deliver their innovation to the world. His latest solution? Enzymatic DNA synthesis. DNA writing is ...

Genetic medicines R&D is making strides with more complex DNA molecules. While these long sequences of synthetic DNA are key for developing gene and cell therapies as well as antibodies and other ...

Stefano de Alessandri, chief of Italy’s Agenzia Nazionale Stampa Associata (ANSA) newswire, had a problem in early April: Fraudsters were publishing fake COVID-19 articles that masqueraded as his.